logo Ibionextlogo Ibionext
  • HOME
  • ABOUT US
  • STRATEGY
  • TEAM
  • OUR COMPANIES
  • NEWS & MEDIA
  • CONTACT
  • Français
Twitter
LinkedIn

Tilak Healthcare Appoints Edouard Gasser as CEO

January 10, 2017Press releasesIbionext
PARIS–(BUSINESS WIRE)–Tilak Healthcare – a start-up from the iBionext network developing medical video games for both the diagnosis and follow-up of chronic diseases, – structures itself and announces the appointment of Edouard Gasser as Chief Executive Officer.

 

Previously Studio Director at Gameloft Madrid – a company developing and editing videogames –, Edouard Gasser will be leading the Tilak Healthcare team, alongside Dr. Serge Fitoussi specialised in the development of pharmaceutical products. The alliance of digital innovation and clinical expertise, unique in the therapeutics videogames world, will allow Tilak Healthcare to offer innovative screening, monitoring and follow-up solutions for many chronic diseases.

Edouard Gasser said: “I am proud to adapt the power of videogames and entertainment to healthcare, and allow Tilak Healthcare to take a unique position within the digital health world. Videogames on mobile phones have all the features to make a great healthcare-oriented tool. I am thrilled to contribute, with Dr. Serge Fitoussi, to this ongoing revolution which gathers the best of both the healthcare and gaming worlds.”

Before heading the Madrid Creation Studio, Edouard successively worked at Gameloft as Project Manager in Paris, then Lead Producer in New Orleans. He was also a writer for TechCrunch France, covering mobile apps, 2.0 web and entertainment topics. In 2011, he cofounded Productism, a social commerce website via social networks.

Alexia Perouse, CEO of iBionext, commented: «We are glad to welcome Edouard, who will be heading the management of Tilak Healthcare. His arrival, coupled with the upcoming team recruitments, mark the end of Tilak Healthcare’s maturation phase within iBionext and the beginning of an acceleration phase aimed at spreading the platform to doctors and patients, in order to become the leader in the development of clinically valued “serious games”.

We chose to position Tilak at the core of the latest videogames advances, to ensure the long-term adoption of our personalized medical solutions within the patients’ standard healthcare pathway.”

About Tilak Healthcare
https://ibionext.com/our-companies/

About iBionext
https://ibionext.com/

Contacts

 

Tilak Healthcare:
Edouard Gasser, +33 (0) 7 62 27 18 42
egasser@tilakhealthcare.com
or
Ibionext Media Relations: NewCap
Annie-Florence Loyer, +33 (0)1 44 71 00 12 / (0)6 88 20 35 59
afloyer@newcap.fr

http://www.businesswire.com/news/home/20170110005713/en/Tilak-Healthcare-Appoints-Edouard-Gasser-CEOJanuary

PR Tilak Healthcare VF clean 3

PR Tilak Healthcare clean 3 English_MB

Previous post 18 janvier 2017: Une matinée iBionext avec l’Association des Directeurs des Organismes de Mutualité (ADOM) Next post Les Mutuelles, nouveaux partenaires de l’innovation ?

SEARCH

ARCHIVES

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

CATEGORIES

  • Events (3)
  • News (78)
  • Press releases (67)

LATEST NEWS

  • Théa partners with Tilak Healthcare to promote OdySight: First remote monitoring solution for ophthalmology June 29, 2022
  • GrAI Matter Labs Unveils Life-Ready AI with GrAI VIP at GLOBAL INDUSTRIE May 16, 2022
  • Rigshospitalet, the main hospital in Denmark based in Copenhagen, collaborate with Chronolife for a clinical investigation in Oncology March 31, 2022
  • Europrotect partners with Chronolife for the development and production of a device to measure physiological data, integrated into a firefighter’s intervention suit to limit the risk of thermal stress March 13, 2022
  • OdySight, first remote monitoring solution in ophthalmology to be reimbursed by the Social Security March 9, 2022

CONTACT US

74, rue du Faubourg Saint-Antoine 75012 Paris
+33 1 76 21 47 50
contact@ibionext.com

LEGAL NOTICES

  • Cookies Policy
  • Privacy Policy
  • Terms of use
© 2023 iBionext. All rights reserved